Valuation: HK inno.N Corporation

Capitalization 1,456B 991M 841M 771M 732M 1.35B 92.15B 1.38B 9.04B 3.56B 44.46B 3.72B 3.64B 157B P/E ratio 2022
27.6x
P/E ratio 2023 * 31x
Enterprise value 1.76B 1.2M 1.02M 934K 887K 1.64M 112M 1.67M 10.96M 4.31M 53.88M 4.5M 4.41M 190M EV / Sales 2022
1.24x
EV / Sales 2023 * 2.13x
Free-Float
51.94%
Yield 2022 *
0.62%
Yield 2023 * 0.62%
1 day-1.72%
1 week+6.31%
Current month+4.79%
3 months+9.36%
6 months+7.76%
Current year+4.26%
1 week 48,450
Extreme 48450
53,600
1 month 46,650
Extreme 46650
53,700
Current year 44,900
Extreme 44900
58,600
1 year 37,100
Extreme 37100
58,600
3 years 27,900
Extreme 27900
58,600
5 years 27,900
Extreme 27900
80,300
10 years 27,900
Extreme 27900
80,300
Manager TitleAgeSince
Chief Executive Officer 65 2022-01-13
Corporate Officer/Principal 59 -
Human Resources Officer 55 -
Director TitleAgeSince
Director/Board Member 51 2021-06-21
Director/Board Member 65 2018-04-17
Director/Board Member 50 2020-09-23
Change 5d. change 1-year change 3-years change Capi.($)
-1.72%+6.31%+37.43%+48.55% 1.01B
-0.80%+4.03%-0.21%-26.53% 60.82B
+0.79%+4.96%+22.71%+107.37% 8.21B
+0.10%-3.78%+12.02%-20.87% 8.17B
-2.37%+4.57%-1.72%+46.10% 5.66B
-0.41%+4.52%-15.86%+80.77% 4.96B
-0.54%+2.25%+68.62%+36.35% 2.96B
+0.05%-0.36%-10.95%-37.28% 2.72B
-0.01%-1.57%+30.72%+29.87% 2.43B
-1.04%+0.43%+89.70%+0.26% 2.01B
Average -0.60%+1.34%+23.25%+26.46% 9.89B
Weighted average by Cap. -0.65%+3.85%+6.56%-1.14%

Financials

2022 2023 *
Net sales 853B 580M 492M 451M 429M 792M 53.98B 809M 5.3B 2.08B 26.04B 2.18B 2.13B 92.03B 827B 563M 478M 438M 416M 768M 52.35B 785M 5.14B 2.02B 25.26B 2.11B 2.07B 89.26B
Net income 42.84B 29.15M 24.74M 22.67M 21.53M 39.79M 2.71B 40.64M 266M 105M 1.31B 109M 107M 4.62B 47.07B 32.02M 27.18M 24.91M 23.65M 43.72M 2.98B 44.65M 292M 115M 1.44B 120M 118M 5.08B
Net Debt 309B 210M 178M 163M 155M 287M 19.53B 293M 1.92B 754M 9.42B 788M 771M 33.3B 307B 209M 178M 163M 155M 286M 19.46B 292M 1.91B 751M 9.39B 785M 768M 33.17B
Logo HK inno.N Corporation
HK Inno.N Corp is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets.
Employees
1,695
Date Price Change Volume
26-04-19 51,400.00 -1.72% 123,540
26-04-17 52,300.00 -1.13% 89,958
26-04-16 52,900.00 +0.95% 136,173
26-04-15 52,400.00 +7.82% 241,686
26-04-14 48,600.00 +0.21% 113,276
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
51,400.00KRW
Average target price
67,615.38KRW
Spread / Average Target
+31.55%
  1. Stock Market
  2. Equities
  3. A195940 Stock